Ocrelizumab for Preventing Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease.

Clinical trial NCT04877457 · TERMINATED

Trial details

NCT number: NCT04877457
Sponsor: Yale University
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Radiologically Isolated Syndrome Multiple Sclerosis

Start date: 2022-02-15
Primary completion: 2023-06-12
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.